Showing results (861-870 of 9,402) with videos related to
Sort By:
Pageof 941
Clinical Pharmacology and Therapeutics|October 25, 2007
New adaptive method for phase I trials in oncologyC Meille, J C Gentet, D Barbolosi, et al.Clinical Pharmacology and Therapeutics|October 25, 2007
Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficultiesJ L Blumer, M D Reed, F Steinberg, et al.Clinical Pharmacology and Therapeutics|November 14, 2007
The importance of including swine and poultry workers in influenza vaccination programsG C Gray, W S BakerClinical Pharmacology and Therapeutics|November 14, 2007
Use of nanocarriers for transdermal vaccine deliveryL B Lawson, L C Freytag, J D ClementsClinical Pharmacology and Therapeutics|June 15, 2007
Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemiaL Wang, A Giannoudis, S Lane, et al.Clinical Pharmacology and Therapeutics|June 16, 2007
Diagnosing model diagnosticsM O Karlsson, R M SavicClinical Pharmacology and Therapeutics|August 19, 2007
Protease inhibitors as immunomodulatory drugs for HIV infectionS G DeeksClinical Pharmacology and Therapeutics|August 24, 2007
Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older womenY-J Cao, D E Mager, E M Simonsick, et al.Clinical Pharmacology and Therapeutics|August 10, 2007
Intravenous parecoxib rapidly leads to COX-2 inhibitory concentration of valdecoxib in the central nervous systemV Mehta, A Johnston, R Cheung, et al.Clinical Pharmacology and Therapeutics|November 7, 2008
Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort studyE L Fosbøl, G H Gislason, S Jacobsen, et al.Pageof 941